City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs
- U.S. IPO: 6 events in the last 90 days
- Previous: earlier the same day · TRex Bio raised $116.7 million in a U.S. IPO, pricing at the bottom of its range
What happened
The Cambridge, Massachusetts company is offering 9.72 million shares at $17 to $19 each and plans to list on Nasdaq under the symbol CTY
Summary assembled by rule from the sources below